Investor Slashes Million From Zymeworks as Stock Jumps 60%
A large holder trimmed a substantial stake in a biotech name while the stock advanced. This piece explains what inves...
Stock index values update on scheduled times or upon data arrivals, varying by index and exchange. This piece covers the timing and implications.
22,965 articlesA large holder trimmed a substantial stake in a biotech name while the stock advanced. This piece explains what inves...
A bold, high‑risk biotech bet can pay off with patience and discipline. This article breaks down iovance biotherapeut...
Adobe sits as a candidate undervalued stock that could rebound in 2026, trading in the low-$280s with a 16x trailing ...
Chevron has kept its promise to shareholders with steady cash returns. Discover how 16 quarters of returns totaling o...
When Occidental Petroleum faced a retreat in stock price, traders asked whether it was a one-off event or a signal. T...
Figma stunned traders with a big Q1 2026 beat, lifting the stock on Friday morning. Here’s what happened, why it matt...
As AI accelerates, a pair of blue-chip picks stands out for a decade-long hold. Learn why these two AI leaders fit th...
When a Planet Labs CEO sells shares, investors take note. This article breaks down what the move could signal, how to...
As Netflix stumbles, investors wonder if Disney down 2026 offers a rare contrarian opportunity. This article digs int...
When a company’s founder or CEO sells a chunk of stock, it sparks questions. This article breaks down the Zoom inside...
A seasoned value investor, Einhorn has long hunted bargains where others fear to tread. This article breaks down how ...
Investors have watched Peloton stumble from its pandemic-era peak to today’s volatile trading. This guide digs into w...